Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease.
Amelie TherrienJocelyn A SilvesterMaureen M LeonardDaniel A LefflerAlessio FasanoCiaran P KellyPublished in: Digestive diseases and sciences (2020)
Budesonide may be effective to induce clinical response in NRCD presenting with diarrhea and VA, but clinical recurrence and lack of mucosal recovery are frequent after tapering. Other diagnoses, including coexisting IBS, may be considered in non-responders to budesonide therapy.